S. 4646 is a bill that aims to reinstate criminal penalties for individuals who charge veterans unauthorized fees for assistance with their claims for benefits from the Department of Veterans Affairs. The legislation seeks to protect veterans from potential exploitation by ensuring that only authorized and legitimate sources can assist them in navigating the benefits system.
Supporters of S. 4646 have praised the bill as a necessary step to protect veterans from fraud and abuse. They emphasize that reinstating criminal penalties will deter unscrupulous individuals from taking advantage of veterans, ensuring that those who have served the country receive the benefits they deserve without incurring unnecessary costs.
Critics of S. 4646 argue that the bill may create additional barriers for veterans seeking assistance with their claims. Some media outlets have raised concerns that the reinstatement of criminal penalties could deter legitimate organizations from helping veterans, potentially leading to confusion and fewer resources available for those in need.
The analysis of bill S. 4646, which aims to reinstate criminal penalties for unauthorized fees charged to veterans, reveals no direct industry overlaps between the sponsor Richard Blumenthal's top donor industries and the subject matter of the bill. The top donor industries do not appear to have a vested interest in veterans' benefits or related legal matters. While there is lobbying activity in the policy area, such as contributions from American Laboratories Pharma, LLC ($45,000) and TotalEnergies EP Mozambique Area 1 ($170,000), these entities do not directly relate to the enforcement of veterans' benefit claims. Therefore, the risk of conflict of interest is assessed as low, as the financial contributions do not indicate a potential for undue influence on the legislation concerning veterans' rights.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| TOTALENERGIES EP MOZAMBIQUE AREA 1 | BALLARD PARTNERS | $170,000 |
| AMERICAN LABORATORIES PHARMA, LLC | FIRST PRINCIPLES STRATEGIES, LLC | $45,000 |
| SEXTONS CREEK ON BEHALF OF INDIANA WESLEYAN UNIVERSITY | FIRST PRINCIPLES STRATEGIES, LLC | $10,000 |
| YC CONSULTING LLC ON BEHALF OF KOREAN INTERNATIONAL TRADE ASSOCIATION | FIRST PRINCIPLES STRATEGIES, LLC | $10,000 |
| OLD NORTH STRATEGIES, LLC ON BEHALF OF EXELA PHARMA SCIENCES, LLC | FIRST PRINCIPLES STRATEGIES, LLC | $10,000 |
| THE CLAPHAM GROUP, LLC ON BEHALF OF CHILDREN'S EQUITY FUND | FIRST PRINCIPLES STRATEGIES, LLC | undisclosed |
| VALIDAS, LLC | FIRST PRINCIPLES STRATEGIES, LLC | undisclosed |
| NATIONAL JEWISH ADVOCACY CENTER ACTION | FIRST PRINCIPLES STRATEGIES, LLC | undisclosed |
| THE HARRIS FIRM, PLLC ON BEHALF OF FORGOTTEN GM BAILOUT VICTIMS | FIRST PRINCIPLES STRATEGIES, LLC | undisclosed |
| HEALTH SUPPLY US | FARRAGUT PARTNERS LLP | undisclosed |
| ARNOLD & PORTER SCHOLER KAYE LLP ON BEHALF OF NORC AT THE UNIVERSITY OF CHICAGO | MCGINLEY LLC | undisclosed |
| VERIZON COMMUNICATIONS, INC. | MCGINLEY LLC | undisclosed |
| CONCORD PARTNERS LLC | BALLARD PARTNERS | undisclosed |
| 23ANDME RESEARCH INSTITUTE | BALLARD PARTNERS | undisclosed |
| ASIMAT AL HADHARAT | BALLARD PARTNERS | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Richard Blumenthal, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
